SPDR S&P Pharmaceuticals ETF (XPH) Holdings $43.17 +0.63 (+1.48%) Closing price 04:10 PM EasternExtended Trading$43.13 -0.04 (-0.09%) As of 04:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock Top 25 XPH HoldingsRankCompanyCurrent PriceWeightShares Held1RPRXRoyalty Pharma$37.58+1.5%3.98%177,9232ELANElanco Animal Health$16.61+0.8%3.80%424,5443AXSMAxsome Therapeutics$104.76+0.4%3.78%56,0534JAZZJazz Pharmaceuticals$111.30-0.7%3.77%54,8245MRKMerck & Co., Inc.$80.73+0.4%3.77%75,4266PFEPfizer$24.57+1.4%3.73%247,4767CORTCorcept Therapeutics$72.30+1.1%3.72%85,0378JNJJohnson & Johnson$173.40+1.1%3.71%39,0199VTRSViatris$9.71+3.4%3.69%674,63710PRGOPerrigo$22.62-0.9%3.67%221,343 Get the Latest News and Ratings for XPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SPDR S&P Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. 11TARSTarsus Pharmaceuticals$47.81-0.3%3.66%147,08112LLYEli Lilly and Company$625.15-2.5%3.54%7,49113OGNOrganon & Co.$9.22+1.2%3.52%601,01514BMYBristol Myers Squibb$45.96+1.3%3.44%120,78015ZTSZoetis$147.34-0.6%3.41%36,42316PBHPrestige Consumer Healthcare$65.61-3.0%3.28%71,17117HRMYHarmony Biosciences$34.192.96%138,58218PCRXPacira BioSciences$25.18+5.9%2.40%172,31619OCULOcular Therapeutix$12.21-0.7%2.32%341,88920ANIPANI Pharmaceuticals$81.45+18.0%2.29%58,38621AMRXAmneal Pharmaceuticals$8.55+4.1%2.19%432,92222XERSXeris Biopharma$6.84+3.6%2.14%660,27723SUPNSupernus Pharmaceuticals$41.22-0.6%2.11%102,74424LGNDLigand Pharmaceuticals$150.06+2.6%1.97%25,82825INVAInnoviva$18.34-0.7%1.96%160,265 Geographic ExposureUnited States91.2%Ireland6.8%Singapore1.8%Currency ExposureUSD100.0%Sector ExposureHealth Care96.6%Energy1.8%Industrials1.3%Industry ExposureBiotechnology58.8%Pharmaceuticals35.2%Health Care Equipment & Supplies2.6%Renewable Energy1.8%Commercial Services & Supplies1.3%SubIndustry ExposureBiotechnology47.4%Pharmaceuticals40.7%Health Care Supplies2.6%Renewable Energy Equipment1.8%Coupon Exposure4-60.2%Maturity Exposure5-100.2% Related Companies and Tools Related Companies Direxion Daily Healthcare Bull 3x Shares Holdings SPDR S&P Health Care Equipment ETF Holdings Invesco S&P SmallCap Health Care ETF Holdings Simplify Health Care ETF Holdings KraneShares MSCI All China Health Care Index ETF Holdings Invesco Dorsey Wright Healthcare Momentum ETF Holdings Invesco Biotechnology & Genome ETF Holdings ALPS Medical Breakthroughs ETF Holdings SPDR S&P Health Care Services ETF Holdings Invesco Pharmaceuticals ETF Holdings This page (NYSEARCA:XPH) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.